AWR Lloyd advises on sale of Vietnam pharmaceutical firm to Korea’s JW group

In 2019, AWR Lloyd advised the FIT Group, one of Vietnam’s fastest growing conglomerates, on the divestment of their shareholding in Euvipharm, a Vietnamese pharmaceuticals company,  to Korean group, JW Pharmaceutical Corporation. The transaction was completed in December 2019. JW Pharmaceutical Corporation is a pharmaceutical company in Korea with core competencies in antibiotics, IV solutions, … Continued